CanSino has yet to release detailed phase three trial data. Photo: Shutterstock Images
CanSino has yet to release detailed phase three trial data. Photo: Shutterstock Images

Chinese drug firm CanSino hoping Brazil will approve Covid-19 vaccine after deal with local company

  • Brazilian firm Biomm has signed an exclusive deal to market and distribute the Chinese company’s product in the country
  • The drug has not yet been approved for emergency use by the WHO and it is unclear if the Brazilian authorities will give it the go-ahead

Topic |   Coronavirus pandemic
CanSino has yet to release detailed phase three trial data. Photo: Shutterstock Images
CanSino has yet to release detailed phase three trial data. Photo: Shutterstock Images
READ FULL ARTICLE